Vanderbilt Kennedy Center

Nashville, Tennessee 37232

1 studies enrolling now · 12 studies all time

What they study most

Autism Spectrum Disorder, Autism Spectrum Disorders, Fragile X Syndrome, Genetic Disease, Genetic Diseases, X-Linked, Intellectual Disability, Nervous System Diseases, Neurobehavioral Manifestations, Neurodevelopmental Disorders, Neurologic Disorder, Neurologic Manifestations, Rett Syndrome

Studies at this site

• Rett Syndrome Registry — Recruiting now
• SENSE Theatre Intervention for Children With Autism Spectrum Disorder (ASD) — Completed
• Biomarker and DNA Collection in Subjects Participating in Protocol 22003 — Completed
• Efficacy and Safety Study of STX209 (Arbaclofen) for Social Withdrawal in Adolescents and Adults With Fragile X Syndrome — Completed
• Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001 — Completed
• Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders — Completed
• Efficacy and Safety Study of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Children With Fragile X Syndrome — Completed
• Open Label Extension Study of STX209 (Arbaclofen) in Autism Spectrum Disorders — Stopped early
• Open-Label Study of the Safety and Tolerability of STX209 in Subjects With Autism Spectrum Disorders — Completed
• Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome — Completed
• An Open Label Extension Study of STX209 in Subjects With Fragile X Syndrome — Stopped early
• An Open Label Extension Study of STX209 in Subjects With Autism Spectrum Disorders — Stopped early